Mechanisms of Disease: mitochondria as new therapeutic targets in diabetic neuropathy
- 1 November 2006
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Neurology
- Vol. 2 (11) , 620-628
Abstract
Diabetic neuropathy (DN) is the most common complication of diabetes mellitus, and it imposes a considerable burden on a patient's quality of life and the health-care system. Despite the prevalence and severity of DN, there are no effective treatments. Pathogenetic evidence suggests that DN is marked by degeneration of dorsal root ganglion (DRG) neurons in peripheral nerves, and that DRG mitochondria are particularly affected. DRG mitochondria are especially vulnerable because they are the origin of reactive oxygen species production in the hyperglycemic neuron. Accumulating evidence indicates that neuronal mitochondria are subject to damage at the level of their DNA, and their outer and inner membranes, and also via deregulation of mitochondrial fission and fusion proteins that control mitochondrial shape and number. This Review will survey the mechanisms of mitochondrial degeneration in the pathogenesis of DN, highlighting potential mitochondrial sites for therapeutic intervention.Keywords
This publication has 63 references indexed in Scilit:
- Poly(ADP-Ribose) Polymerase Inhibition Alleviates Experimental Diabetic Sensory NeuropathyDiabetes, 2006
- Cell Culture Modeling to Test Therapies Against Hyperglycemia-Mediated Oxidative Stress and InjuryAntioxidants & Redox Signaling, 2005
- Regulation of mitochondrial gene expression by energy demand in neural cellsJournal of Neurochemistry, 2005
- Hydrogen Peroxide-Mediated Cytosolic Acidification Is a Signal for Mitochondrial Translocation of Bax during Drug-Induced Apoptosis of Tumor CellsCancer Research, 2004
- Establishment of Stable hFis1 Knockdown Cells with an siRNA Expression VectorThe Journal of Biochemistry, 2004
- High glucose‐induced oxidative stress and mitochondrial dysfunction in neuronsThe FASEB Journal, 2002
- Bcl-XL Protects BimEL-induced Bax Conformational Change and Cytochrome c Release Independent of Interacting with Bax or BimELJournal of Biological Chemistry, 2002
- Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophyNature Genetics, 2000
- Neurons Undergo Apoptosis in Animal and Cell Culture Models of DiabetesNeurobiology of Disease, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998